NCT04560673 2025-12-31
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
3 trialsNCT04970121 2024-09-25
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
The First Affiliated Hospital of Bengbu Medical University
Phase 2 Recruiting
NCT06551051 2024-09-19
ADC-induced Neurotoxicity Treated With Duloxetine
Fudan University
Phase 2 Recruiting